Marvel Biosciences awards 50,001 deferred share units to independent directors
Marvel Biosciences Corp. (and its wholly owned subsidiary) announced the award of 50,001 deferred share units (DSUs) to its three independent directors.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.